港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

宜明昂科-B

6.980

-0.040-0.57%

成交量：304.02萬

成交額：2,171.38萬

市值：28.41億

市盈率：-7.69

高：7.370

開：7.300

低：6.910

收：7.020

資料載入中...

總覽公司新聞資訊公告

南向資金12月20日淨賣出宜明昂科-B193.22萬股連續3日減持

宜明昂科-B(01541)下跌5.3%，報5.0元/股

宜明昂科-B盤中異動臨近收盤急速下挫5.11%

宜明昂科-B盤中異動早盤股價大跌5.13%

宜明昂科-B上榜12月18日主力資金加倉幅度前10個股（附名單）

宜明昂科-B(01541)下跌5.28%，報5.74元/股

宜明昂科-B盤中異動快速下跌5.28%報5.740港元

智通港股早知道 | 央企市值管理新規落地解決長期破淨問題納入年度重點工作

宜明昂科(01541.HK)IMM0306的IB期臨牀試驗完成首例患者給藥

阿斯达克财经

港股公告掘金 | 阿里巴巴-W：擬出售銀泰心泰醫療：ScienCrown®經導管植入式主動脈瓣膜系統取得醫療器械登記證

宜明昂科-B(01541)：IMM0306治療視神經嵴髓炎譜系疾病的IB期臨牀試驗完成首例患者給藥

宜明昂科-B(01541)下跌5.04%，報6.03元/股

宜明昂科-B盤中異動臨近收盤快速跳水5.04%

宜明昂科-B(01541)上漲5.42%，報6.22元/股

宜明昂科－Ｂ(01541)股價上升5.085%，現價港幣$6.2

阿斯达克财经

宜明昂科-B盤中異動下午盤快速下挫5.03%

宜明昂科-B(01541)上漲5.32%，報6.33元/股

宜明昂科-B盤中異動大幅上漲5.32%

醫藥股多數走高來凱醫藥(02105)漲8.37% 24版醫保目錄新增創新藥數量創新高

宜明昂科-B盤中異動股價大漲5.12%報6.370港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01541/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":6.98,"timestamp":1747291358613,"preClose":7.02,"halted":0,"volume":3040200,"delay":0,"floatShares":382000000,"shares":407000000,"eps":-0.9075970308805847,"marketStatus":"交易中","change":-0.04,"latestTime":"05-15 14:43:51","open":7.3,"high":7.37,"low":6.91,"amount":21713754,"amplitude":0.065527,"askPrice":6.98,"askSize":1000,"bidPrice":6.97,"bidSize":20600,"shortable":3,"etf":0,"ttmEps":-0.9075970308805847,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1747296600000},"marketStatusCode":2,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":7.02,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"volumeRatio":1.240255,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":382000000,"roa":"-21.43%","roe":"-44.38%","lyrEps":-0.907597,"volumeRatio":1.240255,"shares":407000000,"dividePrice":0,"high":7.37,"amplitude":0.065527,"preClose":7.02,"low":6.91,"week52Low":3.21,"pbRate":"3.86","psRate":"32.96","week52High":22,"institutionHeld":0,"latestPrice":6.98,"committee":0.907407,"eps":-0.9075970308805847,"divideRate":0,"volume":3040200,"delay":0,"ttmEps":-0.9075970308805847,"open":7.3,"prevYearClose":5.16,"prevWeekClose":6.44,"prevMonthClose":6.25,"prevQuarterClose":5.84,"fiveDayClose":6.39,"twentyDayClose":5.22,"sixtyDayClose":5.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2493272736","title":"南向資金12月20日淨賣出宜明昂科-B193.22萬股 連續3日減持","url":"https://stock-news.laohu8.com/highlight/detail?id=2493272736","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493272736?lang=zh_tw&edition=fundamental","pubTime":"2024-12-23 09:30","pubTimestamp":1734917417,"startTime":"0","endTime":"0","summary":"12月20日，南向资金减持宜明昂科-B193.22万股连续3日减持。截止当日收盘，港股通共持有宜明昂科-B9373.12万股，占流通股24.52%。宜明昂科-B近5个交易日下跌16.45%，港股通累计减持53.24万股；近20个交易日下跌31.10%，港股通累计增持2547.90万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223093145a2034d87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223093145a2034d87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2492871460","title":"宜明昂科-B(01541)下跌5.3%，報5.0元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492871460","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492871460?lang=zh_tw&edition=fundamental","pubTime":"2024-12-20 15:32","pubTimestamp":1734679961,"startTime":"0","endTime":"0","summary":"12月20日，宜明昂科-B(01541)盘中下跌5.3%，截至15:32，报5.0元/股，成交4264.46万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/20153246630860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2492607194","title":"宜明昂科-B盤中異動 臨近收盤急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492607194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492607194?lang=zh_tw&edition=fundamental","pubTime":"2024-12-20 15:32","pubTimestamp":1734679956,"startTime":"0","endTime":"0","summary":"2024年12月20日临近收盘15时32分，宜明昂科-B股票出现异动，股价急速下挫5.11%。截至发稿，该股报5.010港元/股，成交量829.1万股，换手率2.17%，振幅6.25%。资金方面，该股资金流入1225.02万港元，流出1970.16万港元。宜明昂科-B股票所在的生物技术行业中，整体跌幅为0.13%。宜明昂科-B公司简介：宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220153240ab865934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220153240ab865934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2492719385","title":"宜明昂科-B盤中異動 早盤股價大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492719385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492719385?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 09:43","pubTimestamp":1734572609,"startTime":"0","endTime":"0","summary":"2024年12月19日早盘09时43分，宜明昂科-B股票出现异动，股价急速跳水5.13%。截至发稿，该股报5.180港元/股，成交量288.04万股，换手率0.75%，振幅6.04%。资金方面，该股资金流入349.41万港元，流出731.373万港元。宜明昂科-B股票所在的生物技术行业中，整体跌幅为0.72%。宜明昂科-B公司简介：宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121909432995ea62cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121909432995ea62cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2492717369","title":"宜明昂科-B上榜12月18日主力資金加倉幅度前10個股（附名單）","url":"https://stock-news.laohu8.com/highlight/detail?id=2492717369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492717369?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 16:16","pubTimestamp":1734509761,"startTime":"0","endTime":"0","summary":"12月18日, 宜明昂科-B股价跌9.90%，报收5.46元，成交金额1.01亿元，换手率4.66%，振幅12.05%，量比1.63。宜明昂科-B今日主力资金净流入1263万元，上一交易日主力净流入47万元，今日环比增加2587.23%。该股近5个交易日下跌13.39%，主力资金累计净流入970万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出641万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161638a1f7fe4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161638a1f7fe4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2492929031","title":"宜明昂科-B(01541)下跌5.28%，報5.74元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492929031","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492929031?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 13:00","pubTimestamp":1734498037,"startTime":"0","endTime":"0","summary":"12月18日，宜明昂科-B(01541)盘中下跌5.28%，截至13:00，报5.74元/股，成交2667.93万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/18130046527058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2492929517","title":"宜明昂科-B盤中異動 快速下跌5.28%報5.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492929517","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492929517?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 13:00","pubTimestamp":1734498030,"startTime":"0","endTime":"0","summary":"2024年12月18日下午盘13时00分，宜明昂科-B股票出现波动，股价急速下挫5.28%。截至发稿，该股报5.740港元/股，成交量448.34万股，换手率1.17%，振幅7.10%。资金方面，该股资金流入1038.98万港元，流出989.969万港元。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.02%。宜明昂科-B公司简介：宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218130035a1f7a079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218130035a1f7a079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2492917842","title":"智通港股早知道 | 央企市值管理新規落地 解決長期破淨問題納入年度重點工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2492917842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492917842?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 07:41","pubTimestamp":1734478867,"startTime":"0","endTime":"0","summary":"中央企业和控股上市公司要将股票回购增持作为一项长期性基础性工作，建立常态化股票回购增持机制。市场等待美联储今年的最后一次货币政策决议。增持后最新持股数目约为139.11亿股，最新持股比例为16.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226277.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1500","LU0359201885.HKD","LU1166156734.SGD","03143","01541","LU0287142896.SGD","HSCEI","BK1537","01065","LU1880383366.USD","YANG","BK1560","01378","LU0823426308.USD","LU1224709979.USD","IE0032431581.USD","SG9999001093.SGD","LU0737861699.HKD","LU0823426480.USD","BK1592","BK1140","BK1175","HSTECH","01398","BK1521","LU1880383440.USD","LU0702159699.USD","LU0173614495.USD","LU0359201612.USD","BK1231","BK1594","LU1023057109.AUD","LU0359202008.SGD","BK1552","BK1161"],"gpt_icon":1},{"id":"2492999585","title":"宜明昂科(01541.HK)IMM0306的IB期臨牀試驗完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2492999585","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492999585?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 02:32","pubTimestamp":1734460320,"startTime":"0","endTime":"0","summary":"宜明昂科－Ｂ(01541.HK) 公布，集团独立研发的IMM0306(一种靶向CD47xCD20的原创新药双特异性抗体)治疗视神经脊髓炎谱系疾病的Ib期临床试验成功完成首例患者给药，且并无不良事件报告。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-17 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1404758/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03347","BK1141","01541","BK1583","BK1576","BK1161"],"gpt_icon":0},{"id":"2492796623","title":"港股公告掘金 | 阿里巴巴-W：擬出售銀泰    心泰醫療：ScienCrown®經導管植入式主動脈瓣膜系統取得醫療器械登記證","url":"https://stock-news.laohu8.com/highlight/detail?id=2492796623","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492796623?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 22:36","pubTimestamp":1734446187,"startTime":"0","endTime":"0","summary":"【重大事项】阿里巴巴-W(09988)：拟出售银泰宜明昂科-B(01541)：IMM0306治疗视神经嵴髓炎谱系疾病的IB期临床试验完成首例患者给药金利来集团(00533)获主席曾智明溢价约24.85%提私有化 12月18日复牌心泰医疗(02291)：ScienCrown经导管植入式主动脉瓣膜系统取得医疗器械登记证翰森制药(03692)：注射用HS-20110获国家药品监督管理局签发的药物临床试验","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","LU1481107354.HKD","89988","LU2097828474.EUR","YANG","09996","09997","BK4505","LU0823397285.USD","LU1242518931.SGD","LU0456846285.SGD","SG9999001226.SGD","LU1044876610.USD","LU1046422090.SGD","BABA","BK1588","LU0228659784.USD","LU1105468828.SGD","HSCEI","BK4587","LU0329678170.USD","LU0431992006.USD","LU0067412154.USD","SG9999014674.SGD","LU1282649810.SGD","LU0384037296.USD","159883","LU0348825331.USD","LU1224444064.USD","00533","LU0577902611.USD","02291","LU1366334578.USD","LU2097828714.EUR","IE0032431581.USD","LU1808992512.USD","LU2476274308.USD","LU2097828557.USD","BK4502","09988","LU0259732245.USD","01541","LU0164865239.USD","LU1051768304.USD","03692","BK4533","HBBD.SI","LU0541502299.USD","LU0084288322.USD"],"gpt_icon":1},{"id":"2492621931","title":"宜明昂科-B(01541)：IMM0306治療視神經嵴髓炎譜系疾病的IB期臨牀試驗完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2492621931","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492621931?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 18:01","pubTimestamp":1734429718,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 公布，IMM0306治疗视神经嵴髓炎谱系疾病的Ib期临床试验成功完成首例患者给药，且并无不良事件报告。据悉，由该集团独立研发的IMM0306是一种靶向分化簇47及分化簇20的双特异性分子，是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子。截至本公告日期，该集团拥有IMM0306的全球知识产权及商业化权利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01541","BK1141","BK1583","03347","BK1161","BK1576"],"gpt_icon":0},{"id":"2491310440","title":"宜明昂科-B(01541)下跌5.04%，報6.03元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491310440","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491310440?lang=zh_tw&edition=fundamental","pubTime":"2024-12-13 15:51","pubTimestamp":1734076312,"startTime":"0","endTime":"0","summary":"12月13日，宜明昂科-B(01541)盘中下跌5.04%，截至15:51，报6.03元/股，成交4053.93万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/13155146355286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2491348540","title":"宜明昂科-B盤中異動 臨近收盤快速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491348540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491348540?lang=zh_tw&edition=fundamental","pubTime":"2024-12-13 15:51","pubTimestamp":1734076308,"startTime":"0","endTime":"0","summary":"2024年12月13日临近收盘15时51分，宜明昂科-B股票出现波动，股价快速下跌5.04%。截至发稿，该股报6.030港元/股，成交量654.66万股，换手率1.71%，振幅7.09%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。宜明昂科-B股票所在的生物技术行业中，整体跌幅为0.95%。宜明昂科-B公司简介：宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213155148ab74b10e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213155148ab74b10e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2490001611","title":"宜明昂科-B(01541)上漲5.42%，報6.22元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490001611","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490001611?lang=zh_tw&edition=fundamental","pubTime":"2024-12-11 11:44","pubTimestamp":1733888692,"startTime":"0","endTime":"0","summary":"12月11日，宜明昂科-B(01541)盘中上涨5.42%，截至11:44，报6.22元/股，成交2962.69万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/11114446245303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2490001931","title":"宜明昂科－Ｂ(01541)股價上升5.085%，現價港幣$6.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2490001931","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490001931?lang=zh_tw&edition=fundamental","pubTime":"2024-12-11 11:44","pubTimestamp":1733888640,"startTime":"0","endTime":"0","summary":"[上升股]宜明昂科－Ｂ(01541) 股价在上午11:44比前收市价上升5.085%，现股价为港币$6.2。至目前为止，今日最高价为$6.2，而最低价为$5.84。总成交量为467.64万股，总成交金额为港币$2.819千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241211535/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2490051681","title":"宜明昂科-B盤中異動 下午盤快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490051681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490051681?lang=zh_tw&edition=fundamental","pubTime":"2024-12-10 13:08","pubTimestamp":1733807305,"startTime":"0","endTime":"0","summary":"2024年12月10日下午盘13时08分，宜明昂科-B股票出现异动，股价大幅下跌5.03%。截至发稿，该股报5.850港元/股，成交量956.08万股，换手率2.50%，振幅7.31%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。宜明昂科-B股票所在的生物技术行业中，整体跌幅为1.17%。宜明昂科-B公司简介：宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121013082595e89050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121013082595e89050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2490799104","title":"宜明昂科-B(01541)上漲5.32%，報6.33元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490799104","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490799104?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 11:26","pubTimestamp":1733714780,"startTime":"0","endTime":"0","summary":"12月9日，宜明昂科-B(01541)盘中上涨5.32%，截至11:26，报6.33元/股，成交4499.78万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/09112646156033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2490799092","title":"宜明昂科-B盤中異動 大幅上漲5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490799092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490799092?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 11:26","pubTimestamp":1733714778,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘11时26分，宜明昂科-B股票出现波动，股价大幅拉升5.32%。截至发稿，该股报6.330港元/股，成交量731.2万股，换手率1.91%，振幅5.99%。宜明昂科-B股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，永泰生物-B、华康生物医学、药明康德涨幅较大，振幅较大的相关个股有永泰生物-B、晶泰科技、北海康成-B，振幅分别为18.33%、14.86%、14.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120911261898e66b04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120911261898e66b04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2489425384","title":"醫藥股多數走高 來凱醫藥(02105)漲8.37% 24版醫保目錄新增創新藥數量創新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2489425384","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489425384?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 10:16","pubTimestamp":1733451405,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股多数走高，来凯医药 涨8.37%，宜明昂科涨6.11%，药明康德涨4.8%，药明生物涨3.04%，云顶新耀涨1.43%。中信建投研报表示，24版医保目录总体情况，结果稳定，符合预期。国产药品占比显著提升，新增创新药数量创新高，体现对基金安全、民众医疗需求及支持创新的多方平衡。中成药纳入数量稳定提升，中药饮片数量保持稳定。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949112","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002562.SGD","BK1515","LU0823426308.USD","01541","LU0708995583.HKD","BK1576","02269","LU1880383366.USD","LU0516423174.USD","BK1161","LU0456846285.SGD","LU0516422366.SGD","LU0359202008.SGD","BK1521","LU0856984785.SGD","BK1610","LU0417516902.SGD","LU0348825331.USD","LU1242518857.USD","LU0588546209.SGD","LU0052750758.USD","LU0359201612.USD","LU1794554557.SGD","LU0516423091.SGD","LU2045819591.USD","LU0043850808.USD","LU2242644610.SGD","LU0516422440.USD","LU1688375341.USD","LU0181495838.USD","SG9999002463.SGD","02359","LU0039217434.USD","LU0572944931.SGD","06978","LU2125910500.SGD","01952","LU0320764599.SGD","LU0326950275.SGD","159992","02105","LU0307460666.USD","BK1574","159938","LU1720050803.USD","IE00B0JY6N72.USD","LU0348735423.USD","LU0327786744.USD","LU1046422090.SGD","09939"],"gpt_icon":0},{"id":"2489440187","title":"宜明昂科-B盤中異動 股價大漲5.12%報6.370港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489440187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489440187?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 09:41","pubTimestamp":1733449285,"startTime":"0","endTime":"0","summary":"2024年12月06日早盘09时41分，宜明昂科-B股票出现波动，股价快速上涨5.12%。截至发稿，该股报6.370港元/股，成交量316.08万股，换手率0.83%，振幅6.11%。资金方面，该股资金流入937.825万港元，流出430.836万港元。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，巨子生物、北海康成-B、永泰生物-B涨幅较大，振幅较大的相关个股有晶泰科技、宜明昂科-B、来凯医药-B，振幅分别为7.19%、6.11%、5.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206094125971bfd02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206094125971bfd02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盤後","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2025-05-14","current":-8.354374,"percent":0.580723,"low":-30.003263,"twenty":-24.81013,"median":-12.288977,"eighty":-5.744251,"high":-2.993766,"avg":-13.619318,"sd":8.259894,"marketCap":2859300018},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-14","current":-8.354374,"twenty":-24.81013,"median":-12.288977,"eighty":-5.744251,"marketCap":2859300018}],"updateTime":1747269730539}}}